Back to all Areas
F
Materials for Healthcare
Area F covers the full spectrum of biomaterials for healthcare applications — from biofabrication and smart bioresponsive systems to infection control, surface modification, dental and orthopedic biomaterials, polymeric and ceramic scaffolds, metals in medicine, and biobased hydrogels for tissue engineering. Nine symposia bring together materials scientists, biomedical engineers, and clinicians.
9Symposia
23Organizers
118Topics
5Days
Annabel Braem
FEMS Coordinator
Annabel Braem
KU Leuven, Belgium
Biography

Annabel Braem is associate professor in the Department of Materials Engineering at KU Leuven, Belgium, affiliated with the Biomaterials and Tissue Engineering research group and the Laboratory of Complex Surfaces and Interfaces (Complexurf). Her research lies at the intersection of materials engineering and biomedical sciences, aiming to develop hybrid organic/inorganic biomaterials capable of delivering bioactive substances at implant surface across multiple time and length scales. Her work focuses on ceramic additive manufacturing and surface modification techniques for the controlled release and immobilization of biomolecules. She has authored >100 papers (h-index 32) and currently (co-)supervises 8 PhDs (in addition to 4 defended PhDs). She teaches courses on biomaterials in the master’s programmes of Materials Engineering and Biomedical Engineering at KU Leuven. Annabel serves as president-elect of the Belgian Ceramic Society and emeritus-chair of the American Ceramic Society Bioceramics Division. She is a member of the Advisory Editorial Board of Applied Surface Science.

Jürgen Stampfl
ASMET Coordinator
Jürgen Stampfl
TU Wien, Austria
Biography

Jürgen Stampfl studied applied physics at the University of Technology in Graz and obtained his Dipl.-Ing. degree in 1993. After receiving the PhD degree in materials science from the University of Mining and Metallurgy in Leoben in 1996. He worked as research associate at the Rapid Prototyping Lab at Stanford University, USA (1997–2000). In 2001 he joined the Institute of Materials Science and Technology, TU Wien, where he became associate professor for materials science in 2005 and full professor for Materials and Additive Manufacturing in 2017. Currently he is heading the research area Polymers and composites at TU Wien. His expertise lies in the field of lithography-based additive manufacturing technologies and materials development (polymers, ceramics). He is co-founder of two start-up companies (Lithoz GmbH and Cubicure GmbH) providing 3D-printing equipment and materials. From 2015 to 2023 he was managing director of Cubicure. In 2013 and 2019 he received the Houska price, Austria’s most important award for translating research results into industrial applications. Together with Robert Liska, he received the H.F. Mark medal in 2021, honouring the research in material development for 3D-printing.

9 of 9 shown
No symposia match your search.
F1
Biofabrication and 3D Printing of Biomaterials
This symposium addresses the rapidly evolving field of biofabrication and additive manufacturing of biomaterials for biomedical applications. It covers the design, fabrication, and characterization of 3D-printed constructs using polymers, hydrogels, proteins and cells, ceramics, and composite materials. Bridging materials science, engineering, and biology, it fosters interdisciplinary collaboration spanning ink/bioink development, scaffold engineering, organ-on-chip systems, and regulatory pathways. Both fundamental research and translational applications are welcome, with emphasis on innovations enabling clinical translation of biofabricated constructs for tissue engineering, regenerative medicine, and drug delivery.
Description, Topics & Organizers
Biofabrication and 3D printing of biomaterials represent a transformative frontier in materials science and biomedical engineering. The convergence of advanced manufacturing technologies with novel biomaterial formulations has opened unprecedented opportunities for creating patient-specific implants, functional tissue constructs, and sophisticated in vitro models. This symposium provides a forum for researchers, engineers, and clinicians to present and discuss the latest advances in biofabrication technologies, including extrusion-based bioprinting, inkjet printing, stereolithography (SLA), digital light processing (DLP), laser-assisted bioprinting, and multi-material printing strategies. Special attention is given to the development of inks/bioinks and printable biomaterials, including natural and synthetic hydrogels, decellularized extracellular matrix (dECM)-based materials, ceramic and metallic scaffolds, and hybrid composites. Sessions will address printability and shape fidelity, mechanical and biological performance, vascularization strategies, and scalability for clinical manufacturing. Interdisciplinary contributions at the interface of materials science, cell biology, bioreactor engineering, and computational modeling are strongly encouraged.
Bioink formulation and optimisation: hydrogels, dECM, synthetic and natural polymersExtrusion-based bioprinting and fused deposition modelling (FDM) of biomaterialsStereolithography (SLA) and digital light processing (DLP) for tissue scaffoldsInkjet and laser-assisted bioprinting technologies3D printing of ceramic and bioceramic scaffolds (hydroxyapatite, tricalcium phosphate)Biofabrication of vascularised tissue constructs4D printing and shape-memory biomaterialsOrgan-on-chip and in vitro model fabricationPatient-specific implants and prosthetics via additive manufacturingMechanical characterisation and structural integrity of 3D-printed constructsCell-laden bioprinting and post-printing cell viability assessmentDrug delivery systems fabricated by additive manufacturingComputational modelling and simulation of biofabrication processesRegulatory considerations and clinical translation of biofabricated constructsSustainable and biodegradable materials for biofabrication
Tamilselvan Mohan
Tamilselvan Mohan
TU Graz, Austria
Jasper van Hoorick
Jasper van Hoorick
BioInx, Belgium
F2
Smart biomaterials and bioresponsive systems
Smart biomaterials are increasingly central to modern healthcare, capable of sensing, responding, and adapting to biological environments. This class of bioresponsive materials is reshaping therapeutic, diagnostic, and regenerative strategies. The symposium highlights advances in hybrid material systems engineered for adaptive behaviour, including controlled degradation, biochemical feedback, and microenvironment-specific activation. The focus extends to systems enabling therapeutic control, feedback-driven functionality, stimuli-responsive drug delivery, injectable depots, nanotheranostics, and smart scaffolds with improved integration in implantable, regenerative, and diagnostic applications. Contributions span, but are not limited to, smart and bioresponsive materials, encompassing emerging subfields and cross-disciplinary innovations that advance healthcare-focused material systems.
Description, Topics & Organizers
Smart biomaterials are increasingly designed to evolve structurally and functionally over time while integrating multi-modal responsiveness to chemical, mechanical, electrical, and metabolic cues. This topic examines systems that shift behaviour across healing stages or disease progression, coordinating layered, adaptive responses for advanced therapeutic, diagnostic, drug delivery, and regenerative applications. This symposium invites contributions from across the materials science, bioengineering, and healthcare innovation communities to explore emerging strategies in smart and bioresponsive material systems. We welcome research that advances how materials interact with biological environments, whether through sensing, adaptive behaviour, controlled release, stimuli-responsive delivery, injectable depots, structurally tuneable self-assemblies, dynamic interfaces, or microenvironment-specific activation.

Participation is encouraged from groups working in stimulus-responsive biomaterials, bioactive and multifunctional surfaces, soft and hybrid material systems, non-lamellar liquid crystalline systems, mechanobiology-guided design, micro- and nanoscale fabrication, computational or data-driven materials development, and related subfields. We also encourage submissions addressing sensing-actuation coupling, advanced characterization, modelling, manufacturing strategies, translational pathways, and integration with therapeutic or diagnostic technologies.

The aim of this symposium is to bring together diverse perspectives to highlight how intelligent material design, supported by AI-assisted design and optimization, can drive next-generation solutions for implants, regenerative systems, drug delivery, and healthcare-relevant interfaces.
Stimulus-responsive biomaterials - materials that undergo controlled functional changes in response to biochemical, mechanical, electrical, or thermal cues.Adaptive degradation and time-programmed behaviour - systems whose structural or chemical properties evolve across healing stages or disease progression.Dynamic and multifunctional biointerfaces - surfaces engineered to modulate protein interactions, cell fate, or signalling through tunable chemistry or mechanics.Hybrid organic-inorganic material platforms - integrated architectures combining complementary material classes to enhance responsiveness and biological communication.Micro- and nanoscale sensing and actuation - embedded mechanisms enabling local detection, feedback, or controlled therapeutic release at small length scales.Multimodal, evolving bioresponsive systems - materials integrating multiple sensing pathways.AI-assisted design and high-throughput screening of smart biomaterials - Guided screening and optimization of smart biomaterials, AI and machine learning to predict biomaterial properties, and personalized material design.Biomaterials for mRNA, nucleic acid and advanced gene delivery - biomaterials for mRNA, nucleic acid delivery and gene editing, lipid nanoparticles, siRNA, CRISPR, local gene delivery, vaccine biomaterials.3D and 4D printing and programmable biomaterials for tissue engineering, regenerative medicine - 3D and 4D printing of biomaterials, and programmable hydrogels.Smart biomaterials for extracellular vesicle therapies - extracellular vesicle delivery, and EV-loaded hydrogels.Smart biomaterials for organoids and organ-on-chip - organoids, organ-on-chip, tissue-on-chip, biomimetic matrices, alternatives to animal testing.Self-healing biomaterials - self-healing hydrogels, wound dressing. wearable sensors.Stimuli-responsive nanomedicines - pH-responsive nanomedicines, temperature-responsive nanoparticles, cancer therapy, antimicrobial therapy.Smart hydrogels and structurally tunable self-assembled drug depots - in situ forming depots, localized drug delivery, in situ self-assembly.Bioresponsive nanotheranostics - image-guided drug delivery, diagnostics, theranostic drug nanocarriers, infection-responsive nanomaterials, precision nanomedicine, treatment monitoring.
Anan Yaghmur
Anan Yaghmur
University of Copenhagen, Denmark
Swathi N.V. Raghu
Swathi N.V. Raghu
University of Siegen, Germany

Stay Updated

Subscribe to the FEMS EUROMAT 2027 newsletter for the latest updates.

Submit Abstract